Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Patient Considerations for Inhaled Insulin, with Carol Levy, MD
In this special edition recorded at the 84th American Diabetes Association Scientific Sessions, Carol Levy, MD, director of the Mount Sinai Diabetes Center and Type 1 Diabetes Clinical Research, joins the podcast for a deep dive into the INHALE-3 trial and how to incorporate individual patient-level factors into the management strategy of patients with type 1 diabetes who could benefit from inhaled insulin (Afrezza).Their second on-site episode focused on the INHALE-3 trial, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.